IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

Overview Fund Activity

63 hedge funds and large institutions have $45.1M invested in iShares Genomics Immunology and Healthcare ETF in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 13 closing their positions.

Holders
63
Holders Change
-3
Holders Change %
-4.55%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
19
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$7.8M
2
Bank of America
2
Bank of America
North Carolina
$6.4M
3
WBG
3
Wharton Business Group
Pennsylvania
$6.49M
4
CPG
4
Custom Portfolio Group
Colorado
$725K
5
SFFS
5
Stonehage Fleming Financial Services
Jersey
$465K

Top Sellers

1
Jane Street
1
Jane Street
New York
$2.39M
2
Morgan Stanley
2
Morgan Stanley
New York
$2.7M
3
RIG
3
RiverFront Investment Group
Virginia
$0
4
Envestnet Asset Management
4
Envestnet Asset Management
Illinois
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
LPP
76
Life Planning Partners
Florida
– – -82 Closed
CFGS
77
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4